筋萎縮性側索硬化症（ルーゲーリッグ病）治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04097 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、筋萎縮性側索硬化症（ルーゲーリッグ病）治療の世界市場について調査・分析し、筋萎縮性側索硬化症（ルーゲーリッグ病）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、幹細胞療法）、用途別（病院、診断センター、診療所、小売薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の筋萎縮性側索硬化症（ルーゲーリッグ病）治療市場動向 ・主要企業別マーケットシェア ・筋萎縮性側索硬化症（ルーゲーリッグ病）治療の種類別市場規模2014-2019 （化学療法、幹細胞療法） ・筋萎縮性側索硬化症（ルーゲーリッグ病）治療の用途別市場規模2014-2019 （病院、診断センター、診療所、小売薬局） ・筋萎縮性側索硬化症（ルーゲーリッグ病）治療の北米市場：主要企業・種類別/用途別市場規模 ・筋萎縮性側索硬化症（ルーゲーリッグ病）治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・筋萎縮性側索硬化症（ルーゲーリッグ病）治療の中国市場：主要企業・種類別/用途別市場規模 ・筋萎縮性側索硬化症（ルーゲーリッグ病）治療の日本国内市場：主要企業・種類別/用途別市場規模 ・筋萎縮性側索硬化症（ルーゲーリッグ病）治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・筋萎縮性側索硬化症（ルーゲーリッグ病）治療のインド市場：主要企業・種類別/用途別市場規模 ・筋萎縮性側索硬化症（ルーゲーリッグ病）治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GNT Pharma、Amkor Pharma、Synthetic Biologics、Mitsubishi Tanabe Pharma、Avicena、Sanofi） ・筋萎縮性側索硬化症（ルーゲーリッグ病）治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune response, chemical imbalance etc. The symptoms for ALS mainly include fasciculation, respiratory problems, muscles weakness and cramps. The mortality rate in the ALS patients in high due to breathing problem. Increasing in the number of patients affected with ALS is one of the major factor to drive the growth of ALS treatment market. Sporadic and familial are two types of ALS disease, in which sporadic disease is most common disease found with 90–95% of the overall cases in US and the government initiatives to examination the research for rare disease and FDA approvals creates an opportunity for various market players due to which the global market of amyotrophic lateral sclerosis treatment is expected to expand at healthy CAGR during the forecast period. Due to lower prevalence rate, awareness about the disease and low treatment availability hinder the growth of ALS treatment market.  
In 2018, the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment development in United States, Europe and China.

The key players covered in this study
GNT Pharma
Amkor Pharma
Synthetic Biologics
Mitsubishi Tanabe Pharma
Avicena
Sanofi
…

Market segment by Type, the product can be split into
Chemotherapy
Stem Cell Therapy

Market segment by Application, split into
Hospitals
Diagnostic Centres
Clinics
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Stem Cell Therapy
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostic Centres
1.5.4 Clinics
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size
2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions (2014-2025)
2.2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Manufacturers
3.1.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players Head office and Area Served
3.3 Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product/Solution/Service
3.4 Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2014-2019)
4.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
5.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in United States
5.3 United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
5.4 United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

6 Europe
6.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
6.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Europe
6.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
6.4 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

7 China
7.1 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
7.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in China
7.3 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
7.4 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

8 Japan
8.1 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
8.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Japan
8.3 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
8.4 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
9.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
9.4 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

10 India
10.1 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
10.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in India
10.3 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
10.4 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
11.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Central & South America
11.3 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
11.4 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

12 International Players Profiles
12.1 GNT Pharma
12.1.1 GNT Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.1.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.1.5 GNT Pharma Recent Development
12.2 Amkor Pharma
12.2.1 Amkor Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.2.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.2.5 Amkor Pharma Recent Development
12.3 Synthetic Biologics
12.3.1 Synthetic Biologics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.3.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.3.5 Synthetic Biologics Recent Development
12.4 Mitsubishi Tanabe Pharma
12.4.1 Mitsubishi Tanabe Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.4.5 Mitsubishi Tanabe Pharma Recent Development
12.5 Avicena
12.5.1 Avicena Company Details
12.5.2 Company Description and Business Overview
12.5.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.5.4 Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.5.5 Avicena Recent Development
12.6 Sanofi
12.6.1 Sanofi Company Details
12.6.2 Company Description and Business Overview
12.6.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.6.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.6.5 Sanofi Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Market Segments
Table Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Covered
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Stem Cell Therapy Figures
Table Key Players of Stem Cell Therapy
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Diagnostic Centres Case Studies
Figure Clinics Case Studies
Figure Retail Pharmacies Case Studies
Figure Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Report Years Considered
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size 2014-2025 (Million US$)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions 2014-2019
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions 2014-2019
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Manufacturers in 2018
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product/Solution/Service
Table Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Share by Type (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Market Share by Type (2014-2019)
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Share by Application (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Application in 2018
Figure United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2018-2019)
Table United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2014-2019)
Table United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2014-2019)
Figure Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2018-2019)
Table Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2014-2019)
Table Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2014-2019)
Figure China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2018-2019)
Table China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2014-2019)
Table China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2014-2019)
Figure Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2018-2019)
Table Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2014-2019)
Table Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2018-2019)
Table Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2014-2019)
Figure India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2018-2019)
Table India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2014-2019)
Table India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2014-2019)
Figure Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share (2018-2019)
Table Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2014-2019)
Table Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2014-2019)
Table GNT Pharma Company Details
Table GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019) (Million US$)
Figure GNT Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
Table GNT Pharma Recent Development
Table Amkor Pharma Company Details
Table Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)(Million US$)
Figure Amkor Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
Table Amkor Pharma Recent Development
Table Synthetic Biologics Company Details
Table Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)(Million US$)
Figure Synthetic Biologics Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
Table Synthetic Biologics Recent Development
Table Mitsubishi Tanabe Pharma Company Details
Table Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)(Million US$)
Figure Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
Table Mitsubishi Tanabe Pharma Recent Development
Table Avicena Company Details
Table Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)(Million US$)
Figure Avicena Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
Table Avicena Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Share by Regions (2019-2025)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Share by Regions in 2025
Figure United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Product (2019-2025)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Product in 2025
Table Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2019-2025)
Figure Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---